Efficacy, Safety, and Tolerability of Treatments for Systemic Sclerosis-Related Interstitial Lung Disease: A Systematic Review and Network Meta-Analysis
Academic Article
Publication Date:
2020
Short description:
Efficacy, Safety, and Tolerability of Treatments for Systemic Sclerosis-Related Interstitial Lung Disease: A Systematic Review and Network Meta-Analysis / Erre, G.L., Sebastiani, M., Fenu, M.A., Zinellu, A., Floris, A., Cavagna, L., Renzoni, E., Manfredi, A., Passiu, G., Woodman, R.J., Mangoni, A.A.. - In: JOURNAL OF CLINICAL MEDICINE. - ISSN 2077-0383. - 9:8(2020), pp. 1-18. [10.3390/jcm9082560]
abstract:
There is a paucity of head-to-head comparisons of the efficacy and harms of pharmacological treatments for systemic sclerosis-related interstitial lung disease (SSc-ILD).
Iris type:
Articolo su rivista
Keywords:
cyclophosphamide; hematopoietic stem-cell transplantation; interstitial lung disease; mycophenolate mofetil; network meta-analysis; nintedanib; pomalidomide; randomized controlled trials; rituximab; systemic sclerosis
List of contributors:
Erre, Gian Luca; Sebastiani, Marco; Fenu, Maria Antonietta; Zinellu, Angelo; Floris, Alberto; Cavagna, Lorenzo; Renzoni, Elisabetta; Manfredi, Andreina; Passiu, Giuseppe; Woodman, Richard John; Mangoni, Arduino Aleksander
Published in: